David Zhang, PH.D., MBA

alumis inc.

David Zhang, Ph.D., is Senior Vice President and Head of Biometrics and Data Management at Alumis Inc. As part of the founding management team at Alumis, he served as Chief Information Officer responsible for building up capabilities in Biometrics, IT, Facilities and Investor Relations during the early days of the company. Before joining Alumis, David was Vice President of biometrics, data science and digital health at Bristol Myers Squibb following the company’s acquisition of MyoKardia. At MyoKardia, David built the advanced analytics capabilities from the ground up to enable the successful completion of critical study design, data readouts and New Drug Application submission of Mavacamten (CAMZYOS). Prior to MyoKardia, David spent 15 years at Roche/Genentech with increasing responsibilities leading and building biostatistics and strategic innovation functions. He began his pharmaceutical industry career at Eli Lilly and Abbott Laboratories after receiving his Ph.D. in biostatistics with a minor in genetics from UCLA and completing post-doctoral research at Columbia University. In addition to his day job, David is a founding member of the Bay Area Biopharm Statistics Workshop (BBSW) and served as its President in 2022.